M

McKesson Europe AG
XHAM:CLS1

Watchlist Manager
McKesson Europe AG
XHAM:CLS1
Watchlist
Price: 24.4 EUR
Market Cap: 5B EUR
Have any thoughts about
McKesson Europe AG?
Write Note

Gross Margin
McKesson Europe AG

10.3%
Current
11%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
10.3%
=
Gross Profit
2.1B
/
Revenue
20.6B

Gross Margin Across Competitors

No Stocks Found

McKesson Europe AG
Glance View

Market Cap
5B EUR
Industry
Health Care

McKesson Europe AG traces its roots back over a century, intertwining its growth story with the evolving landscape of healthcare in Europe. As a pivotal player in the distribution and retail of pharmaceuticals, McKesson Europe bridges the critical gap between manufacturers and patients. They operate a vast network of pharmacies spread across numerous countries, alongside an extensive distribution system. This infrastructure ensures medicines and health products swiftly reach their destinations, whether it be sprawling urban areas or remote rural locales. Through this network, McKesson Europe not only guarantees the delivery of essential drugs but also emphasizes efficiency and reliability, crafting a reputation that enhances its commercial success. Revenue streams for McKesson Europe derive from its multifaceted approach to healthcare services. The company thrives on both the wholesaling aspect, where it supplies drugs and health products to independent pharmacies and hospitals, and its retail operations through pharmacy chains. Moreover, McKesson Europe extends its business model by providing management services to independent pharmacies, optimizing their operations and supply chains. With the ever-growing demand for healthcare solutions in Europe, the company capitalizes on this pressing need, utilizing its vast logistical capabilities and deep industry knowledge to maintain its position as a leader in the pharmaceutical distribution and retail sectors. This strategic combination of services enables McKesson Europe AG to sustain its business momentum, adapting to the changing needs of the healthcare market.

CLS1 Intrinsic Value
Not Available
M
What is Intrinsic Value?

See Also

Summary
CLS1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLS1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLS1 stock valuation using valuation multiples.
Wall Street Estimates
CLS1 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLS1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
10.3%
=
Gross Profit
2.1B
/
Revenue
20.6B
What is the Gross Margin of McKesson Europe AG?

Based on McKesson Europe AG's most recent financial statements, the company has Gross Margin of 10.3%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 216,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.